The largest database of trusted experimental protocols

Biolite cell culture treated dishes

Manufactured by Thermo Fisher Scientific
Sourced in United States

The BioLite Cell Culture Treated Dishes are sterile, single-use culture dishes designed for cell culture applications. These dishes feature a treated surface that promotes cell attachment and growth. The dishes are available in various sizes to accommodate different experimental requirements.

Automatically generated - may contain errors

5 protocols using biolite cell culture treated dishes

1

Human iPSC Culture and Passaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human iPSCs (male WTC11 background, Coriell Catalog (Cat.) No. GM25256) were cultured in StemFlex Basal Medium (Gibco; Cat. No. A33493-01) on BioLite Cell Culture Treated Dishes (Thermo Fisher Scientific; assorted Cat. Nos.) coated with Growth Factor Reduced, Phenol Red-Free, LDEV-Free Matrigel Basement Membrane Matrix (Corning; Cat. No. 356231) diluted 1:100 in Knockout DMEM (GIBCO/Thermo Fisher Scientific; Cat. No. 10829-018). StemFlex was replaced every other day or every day once 50% confluent. When 70–80% confluent, cells were passaged by aspirating media, washing with DPBS (Gibco; Cat. No. 14190-144), incubating with StemPro Accutase Cell Dissociation Reagent (GIBCO/Thermo Fisher Scientific; Cat. No. A11105-01) at 37 °C for 7 min, diluting Accutase 1:5 in StemFlex, collecting cells in conicals, centrifuging at 220g for 5 min, aspirating supernatant, resuspending cell pellet in StemFlex supplemented with 10 nM Y-27632 dihydrochloride ROCK inhibitor (Tocris; Cat. No. 125410), counting and plating onto Matrigel-coated plates at the desired number. Human iPSC studies at the University of California, San Francisco were approved by the Human Gamete, Embryo and Stem Cell Research Committee.
+ Open protocol
+ Expand
2

Engineered 3D Cardiac Microtissue Fabrication

Check if the same lab product or an alternative is used in the 5 most similar protocols
Petri dishes (BioLite Cell Culture Treated Dishes, Thermo Scientific) were coated with 5% pluronic F-68 solution (Gibco) and incubated overnight at 4 °C; then, the pluronic solution was removed, and a sterile, modified Delrin frame (1 cm × 2 cm) was secured to the dish with 2% agarose. hCMPs were assembled in three layers over a three-day period (one layer per day). Each layer was generated by depositing 600 μL of an hiPSC-CM–containing fibrin solution (Gao et al., 2018 (link); Pretorius et al., 2020 (link), 2021 (link)) (10 × 106 cells/mL) into the frame (Pretorius et al., 2020 (link), 2021 (link)); then, after fibrin polymerization, the layer was cultured in STEMdiff Cardiomyocyte Support Medium with 2 mg/mL ε-aminocaproic acid overnight at 37 °C and 5% CO2; the procedure was repeated twice to form the second and third layers. After the third cell layer was generated, the frame containing the engineered tissue was lifted off of the petri dish and placed on a custom-cut polydimethylsiloxane (PDMS) platform; then, the hCMP was cultured in fresh culture medium consisting of 2% fetal bovine serum (FBS), 2% B27+ (Gibco), and 2 mg/mL ε-aminocaproic acid in RPMI (Gibco) for one week before the maturation protocols were initiated.
+ Open protocol
+ Expand
3

Establishing M-MuLV-infected 43D Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Establishment of 43D mouse fibroblast cell line stably infected with the wild-type M-MuLV was described previously [21 (link)]. The 43D cells were cultured with DMEM media containing 10% Hyclone calf serum (GE Healthcare Life Sciences, PA), 100 IU/ml of Penicillin and 100ug/ml of Streptomycin (Corning, VA) at 37°C with 5% CO2. Cells were cultivated in 60 mm and 100 mm BioLite cell culture treated dishes (Thermo Scientific, MA, USA). The 43D cells were treated with betulinic acid, its derivatives, or benzalkonium chloride (BKC) for 24 hrs, and then the media were replaced. The cells and viruses were gathered 24 hrs further incubation after the second treatment of the chemicals.
+ Open protocol
+ Expand
4

Cell Culture Protocols for Diverse Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
THP−1 cells were obtained from ATCC (Batch# 62454382) and propagated in T-75 flasks between 0.2 and 1 × 106 cells/mL in an RPMI-1640 (Catalog# 11875093, Gibco, Billings, MT, USA) growth medium. THP−1 experiments were conducted on cells between passage 10 and 15. HEK293T cells were obtained from ATCC (CRL-3216, Batch# 70049877) and grown in 10 cm BioLite™ Cell Culture Treated Dishes (Catalog# 12-556-002, Thermo Scientific, Waltham, MA, USA) in Dulbecco’s Modified Eagle Medium, high glucose (Catalog# 11965092, Gibco, Billings, MT, USA). HEK293T experiments were conducted on cells between passage 20 and 25. A549 cells were obtained from ATCC (CRM-CCL-185, Batch# 70045215) and grown in 10 cm BioLite™ Cell Culture Treated Dishes in Ham’s F-12K (Kaighn’s) Medium (Catalog# 21127022, Gibco, Billings, MT, USA). A549 experiments were conducted on cells between passage 10 and 15. H1 human embryonic stem cells (H1-hESCs) were obtained from WiCell (Madison, Wisconsin, USA Cat# WAe001-A) and grown in Matrigel (Catalog# 354277, Corning, Corning, New York, USA.)-coated 12-well plates in an Essential 8™ Medium (Catalog# A1517001, Gibco, Billings, MT, USA). Each culture medium was supplemented with 10% fetal bovine serum and 1% penicillin–streptomycin. Cells were kept in a humidified atmosphere at 37 °C with 5% CO2.
+ Open protocol
+ Expand
5

Human iPSC Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human iPSCs (in the male WTC11 background (Miyaoka et al., 2014) were cultured in StemFlex Medium on BioLite Cell Culture Treated Dishes (Thermo Fisher Scientific; assorted Cat. No.) coated with Growth Factor Reduced, Phenol Red-Free, LDEV-Free Matrigel Basement Membrane Matrix (Corning; Cat. No. 356231) diluted 1:100 in Knockout DMEM (GIBCO/Thermo Fisher Scientific; Cat. No. 10829–018). Routine passaging was performed as described 23 (link). Studies with human iPSCs at UCSF were approved by the The Human Gamete, Embryo and Stem Cell Research (GESCR) Committee. Informed consent was obtained from the human subjects when the WTC11 (Miyaokaet al., 2014) lines were originally derived.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!